Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This completely nullifies its bacteriostatic properties
Request certificates of analysis, or CoA, from suppliers to confirm whats actually in the product
Physicochemical characterization included particle size distribution, polydispersity index (PDI), and zeta potential (ZP) analysis by dynamic light scattering (DLS), with measurements performed in triplicate (Table 1)
In 2020, combined DRP-104 with atezolizumab (anti-PD-1) entered the clinical trial (NCT04471415) in the treatment of advanced solid tumors (Johnson et al., 2021)
net peptide content or assay value
US$ 24.56
US$ 20.79
US$ 20.45
US$ 21.44
US$ 29.48
US$ 23.86
US$ 29.76
US$ 23.87
